- Home
- BMA vs PTCT Comparison
BMA vs PTCT Comparison
Compare BMA & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMA
- PTCT
- Stock Information
- Founded
- BMA 1966
- PTCT 1998
- Country
- BMA Argentina
- PTCT United States
- Employees
- BMA N/A
- PTCT N/A
- Industry
- BMA Commercial Banks
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- BMA Finance
- PTCT Health Care
- Exchange
- BMA Nasdaq
- PTCT Nasdaq
- Market Cap
- BMA 4.2B
- PTCT 4.1B
- IPO Year
- BMA 2006
- PTCT 2013
- Fundamental
- Price
- BMA $44.35
- PTCT $59.90
- Analyst Decision
- BMA Hold
- PTCT Buy
- Analyst Count
- BMA 3
- PTCT 14
- Target Price
- BMA $50.75
- PTCT $67.00
- AVG Volume (30 Days)
- BMA 709.4K
- PTCT 1.3M
- Earning Date
- BMA 08-27-2025
- PTCT 11-06-2025
- Dividend Yield
- BMA 1.70%
- PTCT N/A
- EPS Growth
- BMA N/A
- PTCT N/A
- EPS
- BMA 0.50
- PTCT 7.72
- Revenue
- BMA $2,573,417,306.00
- PTCT $1,764,929,000.00
- Revenue This Year
- BMA N/A
- PTCT $119.89
- Revenue Next Year
- BMA $11.90
- PTCT N/A
- P/E Ratio
- BMA $8.77
- PTCT $7.64
- Revenue Growth
- BMA N/A
- PTCT 96.00
- 52 Week Low
- BMA $42.17
- PTCT $33.58
- 52 Week High
- BMA $118.42
- PTCT $62.18
- Technical
- Relative Strength Index (RSI)
- BMA 30.10
- PTCT 67.99
- Support Level
- BMA $42.17
- PTCT $58.87
- Resistance Level
- BMA $48.05
- PTCT $62.18
- Average True Range (ATR)
- BMA 2.87
- PTCT 2.00
- MACD
- BMA -0.87
- PTCT 0.47
- Stochastic Oscillator
- BMA 11.44
- PTCT 82.72
About BMA Banco Macro S.A. ADR (representing Ten Class B)
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.